000303502 001__ 303502
000303502 005__ 20250824022527.0
000303502 0247_ $$2doi$$a10.1007/s00393-025-01693-1
000303502 0247_ $$2pmid$$apmid:40802055
000303502 0247_ $$2ISSN$$a0340-1855
000303502 0247_ $$2ISSN$$a1435-1250
000303502 0247_ $$2altmetric$$aaltmetric:180445137
000303502 037__ $$aDKFZ-2025-01693
000303502 041__ $$aGerman
000303502 082__ $$a610
000303502 1001_ $$00000-0002-9171-3780$$aDreher, Matthias$$b0
000303502 245__ $$aRheuma in motion-A positioning of exercise and movement therapy in chronic inflammatory rheumatic diseases.[Rheuma bewegt – Eine Verortung der Sport- und Bewegungstherapie bei chronisch entzündlich-rheumatischen Erkrankungen].
000303502 260__ $$aDarmstadt$$bSteinkopff$$c2025
000303502 3367_ $$2DRIVER$$aarticle
000303502 3367_ $$2DataCite$$aOutput Types/Journal article
000303502 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1755854797_6501$$xReview Article
000303502 3367_ $$2BibTeX$$aARTICLE
000303502 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303502 3367_ $$00$$2EndNote$$aJournal Article
000303502 500__ $$a2025 Aug;84(6):425-437
000303502 520__ $$aPhysical activity and targeted exercise have scientifically proven health benefits and are increasingly being used in the treatment of inflammatory rheumatic diseases. Studies and guidelines show that exercise is safe and effective, improves subjective well-being and positively influences objective clinical parameters.The current literature was systematically reviewed to evaluate the evidence for the use of sport and exercise therapy in rheumatic diseases. Recommendations from international professional societies and recent studies were considered.Exercise therapy plays a central role in the prevention and treatment of various chronic diseases, including inflammatory rheumatic conditions, such as rheumatoid arthritis, spondylarthritis, psoriatic arthritis and collagenosis. For some diseases, such as vasculitides, specific recommendations are still lacking. Different types of training (endurance, strength, flexibility, coordination) can be combined according to individual needs and capabilities. The design of the training type, intensity, frequency and duration must be individually adapted to the disease profile, comorbidities, medication and fitness level.Sport and exercise therapy is not a one-size-fits-all approach but a personalized, evidence-based treatment concept. The therapy must consider the specific disease, its severity, comorbidities and the general health status of the patient. Overall, physical activity and exercise act as a safe broad spectrum medication that improves function, quality of life and comorbidities without increasing disease activity or causing flares.
000303502 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000303502 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303502 650_7 $$2Other$$aExercise
000303502 650_7 $$2Other$$aPhysical activity
000303502 650_7 $$2Other$$aQuality of life
000303502 650_7 $$2Other$$aTherapy
000303502 650_7 $$2Other$$aTraining forms
000303502 7001_ $$0P:(DE-He78)e53808760d4a3e1e967b148feba75a60$$aKöppel, Maximilian$$b1$$udkfz
000303502 7001_ $$00000-0002-4450-7351$$aBaumann, Freerk T$$b2
000303502 7001_ $$00000-0003-2981-5062$$aBiehl, Christoph$$b3
000303502 7001_ $$00000-0002-0566-598X$$aSchwarting, Andreas$$b4
000303502 773__ $$0PERI:(DE-600)1463308-5$$a10.1007/s00393-025-01693-1$$n6$$p425-437$$tZeitschrift für Rheumatologie$$v84$$x0340-1855$$y2025
000303502 909CO $$ooai:inrepo02.dkfz.de:303502$$pVDB
000303502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e53808760d4a3e1e967b148feba75a60$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000303502 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000303502 9141_ $$y2025
000303502 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-12$$wger
000303502 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-12$$wger
000303502 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-12$$wger
000303502 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bZ RHEUMATOL : 2022$$d2024-12-12
000303502 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-12
000303502 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lAngewandte Tumor-Immunität$$x0
000303502 980__ $$ajournal
000303502 980__ $$aVDB
000303502 980__ $$aI:(DE-He78)D120-20160331
000303502 980__ $$aUNRESTRICTED